- Integration of CiNii Books functions for fiscal year 2025 has completed
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on November 26, 2025】Regarding the recording of “Research Data” and “Evidence Data”
- Incorporated Jxiv preprints from JaLC and adding coverage from NDL Search
Bosentan Ameliorated Exercise-Induced Pulmonary Arterial Hypertension Complicated with Systemic Sclerosis
-
- Yagi Shusuke
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Akaike Masashi
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Niki Toshiyuki
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Yoshida Sumiko
- Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences
-
- Yamaguchi Koji
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Kusunose Kenya
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Iwase Takashi
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Sumitomo-Ueda Yuka
- Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences
-
- Koshiba Kunihiko
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Aihara Ken-ichi
- Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences
-
- Hirata Yoichiro
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Dagvasumberel Munkhbaatar
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Tomita Noriko
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Taketani Yoshio
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Yamada Hirotsugu
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Soeki Takeshi
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Wakatsuki Tetsuzo
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
-
- Matsumoto Toshio
- Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences
-
- Sata Masataka
- Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences
Bibliographic Information
- Published
- 2010
- Resource Type
- journal article
- DOI
-
- 10.2169/internalmedicine.49.3812
- Publisher
- The Japanese Society of Internal Medicine
Search this article
Description
Pulmonary arterial hypertension (PAH) is a frequent complication in patients with systemic sclerosis. Bosentan is used in patients with symptomatic PAH; however, it has not been established whether or not bosentan ameliorates the progression of PAH in patients with no PAH-related symptoms.<br> We present a case of systemic sclerosis with no PAH-related symptoms in which bosentan ameliorated exercise-induced PAH evaluated by 6-minute walk stress echocardiography, brachial flow-mediated dilation, and skin temperature of hands and feet. The results suggest that administration of bosentan in patients with early-stage PAH ameliorates pulmonary arterial vasodilatation through improvement of endothelial function.<br>
Journal
-
- Internal Medicine
-
Internal Medicine 49 (21), 2309-2312, 2010
The Japanese Society of Internal Medicine
